Chesapeake Urology Associates

What Chesapeake Urology Associates does

Chesapeake Urology Associates (CUA), operating as Chesapeake Urology Specialists, is a specialty urology medical practice founded in 2006 and headquartered in Owings Mills, Maryland. The practice serves patients across Maryland, the Mid-Atlantic region, and southern Delaware through three clinic locations spanning Anne Arundel, Howard, and Queen Anne's counties. CUA provides diagnostic and treatment services for urological conditions to men, women, and children, and employs between 501 and 1,000 staff.

The practice operates as an affiliate of United Urology Group within the OneOncology platform, a healthcare practice network designed to facilitate clinical integration, shared protocols, and access to oncology resources. In late 2025, CUA expanded its service offering through a partnership with Chesapeake Oncology-Hematology Associates (COHA), integrating medical oncology capabilities — including advanced cancer therapies, clinical trial access, and multidisciplinary care — under a single platform. This makes the combined entity a leading provider of integrated urology and oncology care in the DMV region.

CUA generates revenue through professional services for clinical healthcare delivery, with pricing not publicly disclosed. The go-to-market model is direct patient care through in-person clinic visits, complemented by a partnership-based growth strategy facilitated by OneOncology. The practice is privately held, with Sanford J. Siegel serving as Chief Executive Officer. Ownership and recapitalization activity is managed through United Urology Group, with Provident Healthcare Partners acting as financial advisor on the COHA transaction. The company has historically pursued growth through acquisitions, including Arizona Urology Specialists in 2019.

Name

Chesapeake Urology Associates

Website

https://unitedurology.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Chesapeake Urology Associates is a Maryland-based urology specialty practice providing diagnostic and treatment services across three clinic locations, now expanded into integrated oncology care via its COHA partnership within the OneOncology platform.

Ownership category

akta.pro rank

Product category

Urology Specialty Healthcare

NAICS

Offices of Physicians (62111)

SIC

Services-Offices & Clinics Of Doctors Of Medicine (8011), Services-Health Services (8000)

akta.pro primary industry

Urologic Oncology (HLAKAOAB)

akta.pro secondary industries

Medical Oncology (HLAKAFAB), Genitourinary Oncology (HLAKAFAM)

Keywords

• Urology medical services
• Urologic cancer treatment
• Integrated oncology care
• Specialty urology practice
• Ambulatory healthcare services

Headquarters

HQ city

Owings Mills

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Clinical Healthcare Services: Revenue generated from providing urology medical services to patients, with integrated oncology services following the partnership with COHA. Services include advanced cancer therapies, clinical trials, and multidisciplinary care within local communities.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels1 record

Core offering

Chesapeake Urology Associates operates as Chesapeake Urology Specialists (CUA), a urology specialty medical practice affiliated with United Urology Group and operating on the OneOncology platform. The practice provides diagnostic and treatment services for urological conditions in men, women, and children, and has expanded into integrated urology and medical oncology care through a partnership with Chesapeake Oncology-Hematology Associates (COHA), offering advanced cancer therapies, clinical trials, and multidisciplinary care within community settings across Maryland and the Mid-Atlantic region.

Product overview

Chesapeake Urology Associates operates as Chesapeake Urology Specialists (CUA), a urology specialty medical practice affiliated with United Urology Group and operating on the OneOncology platform. The practice provides integrated urology and medical oncology care services, offering advanced cancer therapies, clinical trials, and multidisciplinary care within local communities across Maryland and the Mid-Atlantic region, including southern Delaware. The practice recently expanded through a partnership with Chesapeake Oncology-Hematology Associates (COHA) to provide integrated urology and medical oncology care under one platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Chesapeake Urology Specialists (CUA)

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core.

• OneOncologycoreStrategic or Co-development Partner · 19 November 2025Chesapeake Urology Associates operates as an affiliate of United Urology Group on the OneOncology platform. OneOncology facilitates partnership opportunities and provides a network for clinical integration, including the partnership with Chesapeake Oncology-Hematology Associates to expand integrated urology and oncology care services.
• United Urology GroupcoreStrategic or Co-development Partner · 19 November 2025Chesapeake Urology Associates is an affiliate of United Urology Group, operating on the OneOncology platform. United Urology Group provides organizational support and includes multiple urology practice affiliates across multiple states including Tennessee, Arizona, and Colorado.
• Chesapeake Oncology-Hematology AssociatescoreStrategic or Co-development Partner · 19 November 2025COHA joins Chesapeake Urology Associates in a partnership facilitated by OneOncology to provide integrated urology and medical oncology care. The collaboration aims to improve access to advanced cancer therapies, clinical trials, and multidisciplinary care within local communities. COHA is the leading oncology provider in the DMV region with five medical oncologists, two advanced practice providers, and three clinics across Anne Arundel, Howard, and Queen Anne's counties in Maryland.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Tennessee Urology Specialists: Sister urology practice under United Urology Group on the OneOncology platform serving Knoxville and surrounding communities; same operating model, governance, and platform dependencies as Chesapeake Urology Associates.
• Arizona Urology Specialists: UUG-affiliated urology practice serving Phoenix/Scottsdale; previously acquired by Chesapeake Urology Associates in 2019, making it a directly comparable platform peer with similar specialty mix and delivery model.
• Colorado Urology Specialists: UUG-affiliated urology practice serving Denver; same multi-clinic community urology model and OneOncology affiliation as CUA.
• US Urology Partners: PE-backed national urology practice platform consolidating independent urology groups; directly comparable specialty focus, multi-site model, and capital structure to CUA/UUG.
• Solaris Health (Solar Medical): Urology-focused management services organization consolidating urology practices across multiple states; competes for the same physician partners and acquisition targets as UUG/CUA.
• Genesis Healthcare Partners: Specialty physician group with strong urology and oncology presence in the western U.S.; comparable integrated urology/oncology service model and multi-site delivery footprint.

Regional players

• Carolina Urology Partners: Multi-physician urology group serving the Carolinas; comparable specialty focus and community-based delivery, but operates in a different geographic market from CUA.

Broad incumbents

• New York-Presbyterian/Weill Cornell Urology: Large academic urology program within a major health system; competes with CUA for complex urology cases in the broader Mid-Atlantic/Northeast referral corridor.
• Johns Hopkins Medicine: Major Maryland-based academic health system with strong urology and oncology programs; primary regional competitor for tertiary referrals that CUA's community clinics might otherwise capture.

Others

• OneOncology: Parent platform that powers CUA's clinical integration, research, and partnership network; relevant as ecosystem participant and indirect competitor for physician practice affiliations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/chesurology

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chesapeake Urology Associates